rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2001-2-9
|
pubmed:abstractText |
To determine the safety and efficacy of fluvoxamine for the treatment of children and adolescents with obsessive-compulsive disorder (OCD) with a double-blind, placebo-controlled, multicenter study.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0890-8567
|
pubmed:author |
pubmed-author:ClaghornJ LJL,
pubmed-author:GaffneyGG,
pubmed-author:GreistJ HJH,
pubmed-author:HollandDD,
pubmed-author:McConvilleB JBJ,
pubmed-author:PigottTT,
pubmed-author:ReeveE AEA,
pubmed-author:RiddleM AMA,
pubmed-author:WalkupJ TJT,
pubmed-author:YangH MHM,
pubmed-author:Yaryura-TobiasJ AJA
|
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
222-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11211371-Adolescent,
pubmed-meshheading:11211371-Age Factors,
pubmed-meshheading:11211371-Analysis of Variance,
pubmed-meshheading:11211371-Child,
pubmed-meshheading:11211371-Dose-Response Relationship, Drug,
pubmed-meshheading:11211371-Double-Blind Method,
pubmed-meshheading:11211371-Female,
pubmed-meshheading:11211371-Fluvoxamine,
pubmed-meshheading:11211371-Humans,
pubmed-meshheading:11211371-Male,
pubmed-meshheading:11211371-Obsessive-Compulsive Disorder,
pubmed-meshheading:11211371-Serotonin Uptake Inhibitors,
pubmed-meshheading:11211371-United States
|
pubmed:year |
2001
|
pubmed:articleTitle |
Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.
|
pubmed:affiliation |
Division of Child and Adolescent Psychiatry, Johns Hopkins Hospital, CMSC 346, 600 North Wolfe Street, Baltimore, MD 21287-3325, USA. mriddle@jhmi.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|